Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 adjunctive EVP-6124 for cognitive impairment in schizophrenia
2012-003208-10Phase 3Completed
- Sponsor
- FORUM Pharmaceuticals
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of encenicline in schizophrenia, sponsored by FORUM Pharmaceuticals. Started Apr 2013; status: completed.
02
Drugs
encenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2012-003208-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003208-10.